CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-29 | Klinger Shannon Thyme Chief Legal Officer | Sale 10b5-1 | −1,418 | $42.79 | $61K | 19,717 |
| 2024-11-29 | Hoge Stephen President | Sale 10b5-1 | −291 | $42.79 | $12K | 1,443,567 |
| 2024-11-27 | Mock James M Chief Financial Officer | Exercise or conversion 10b5-1 | +1,326 | 10,831 | ||
| 2024-11-27 | Mock James M Chief Financial Officer | Exercise or conversion 10b5-1 | +329 | 11,160 | ||
| 2024-11-27 | Mock James M Chief Financial Officer | Exercise or conversion 10b5-1 | +1,326 | 12,486 | ||
| 2024-11-27 | Mock James M Chief Financial Officer | Exercise or conversion · Performance Stock Units 10b5-1 | −1,326 | 1,326 | ||
| 2024-11-27 | Mock James M Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −329 | 2,959 | ||
| 2024-11-27 | Mock James M Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,326 | 1,326 | ||
| 2024-11-27 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +329 | 18,483 | ||
| 2024-11-27 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +2,652 | 21,135 | ||
| 2024-11-27 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −329 | 2,959 | ||
| 2024-11-27 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −2,652 | 2,653 | ||
| 2024-11-27 | Hoge Stephen President | Exercise or conversion 10b5-1 | +610 | 1,443,858 | ||
| 2024-11-27 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −610 | 5,495 | ||
| 2024-11-11 | Hoge Stephen President | Sale 10b5-1 | −277 | $46.10 | $13K | 1,443,248 |
| 2024-11-08 | Hoge Stephen President | Exercise or conversion 10b5-1 | +523 | 1,443,525 | ||
| 2024-11-08 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −523 | 523 | ||
| 2024-10-07 | Mock James M Chief Financial Officer | Sale 10b5-1 | −715 | $60.12 | $43K | 9,505 |
| 2024-10-04 | Mock James M Chief Financial Officer | Exercise or conversion 10b5-1 | +1,453 | 10,220 | ||
| 2024-10-04 | Mock James M Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,453 | 11,622 |
Page 22 of 38 · 743 trades